Stocks to Buy

Identifying winning stocks requires more than scanning headlines. InvestorPlace analysts focus on long-term themes, market timing, and structural shifts shaping where capital is flowing next, highlighting stocks positioned to benefit from those trends.

Traders Should Capitalize After the Sharp Dip in Cloudflare Stock

By Louis Navellier and the InvestorPlace Research Staff
There's no need to get shaken out of the trade with NET stock as Cloudflare continues to push the boundaries of internet speed and security.

Nvidia Commands Respect on Wall Street

By Nicolas Chahine, InvestorPlace Contributor
The fundamental argument for NVDA stock is a slam dunk. With a bit of common sense, it becomes easy to invest in this winner.

Accept Volatility in Moderna As It Should Prevail in Time

By Louis Navellier and the InvestorPlace Research Staff
There's no need to abandon MRNA stock now as Moderna remains an aggressive pioneer in advancing mRNA therapeutics.

No Fear: CrowdStrike Stock Is a Buy

By Louis Navellier and the InvestorPlace Research Staff
There are times when a company beats earnings but the stock falls anyway. It's a great opportunity -- and it's happening with CRWD stock.

7 Top-Rated Pharmaceutical Stocks To Invest in for October

By Louis Navellier and the InvestorPlace Research Staff
It's a great time to look beyond the big name pharmaceutical stocks and look for great niche players with big futures.

Best Stocks for 2021: Enterprise Products Is Still an Income Machine

By Charles Sizemore, Chief Investment Strategist, The Freeport Society
Enterprise Products is an income-paying workhorse trading at a fantastic price, making EPD stock still one of the best stocks of 2021.

3 Best Housing Stocks to Buy as Mortgage Rates Remain Below 3%

By Muslim Farooque, InvestorPlace Contributor
These housing stocks are cashing-in on the ongoing strength in the housing industry and are likely to end the year on a high

High Analyst Price Targets Make SoFi Technologies Worth Considering

By David Moadel, InvestorPlace Contributor
Whether investors are ready or not, there's a neo-banking revolution in progress, and you can profit from it with SOFI stock.

Hyliion Commercialization Should Offer Catalyst To Reverse 50% Share Drop

By Joseph Nograles
Despite HYLN stock underperforming, there have been new developments in Hyliion. These developments include a new COO and new orders from a major customer.

Use Cassava Sciences Stock Weakness as Buy Opportunity Ahead of Phase 3

By Ian Cooper, InvestorPlace Contributor
If Cassava Sciences' Alzheimer drug can continue to produce solid results, it could see FDA approval before the end of 2022. SAVA stock may not be oversold for long.

3 Reasons to Buy the Dips in Nvidia Stock

By Bret Kenwell, InvestorPlace Contributor
Nvidia is truly one of the best stocks of the past few years and the hope is that NVDA stock will remain that way going forward.

4 Top Stock Trades for Monday: BTC, ETH, NVAX, MRNA

By Bret Kenwell, InvestorPlace Contributor
Bitcoin, Ethereum, Novavax and Moderna were our top stock trades for Monday. Now, let's look at how the charts are setting up for next week.

3 International Tech Stocks to Buy Right Now

By David Cohne, StockNews.com
Multiple concerns hang over investors right now which has created increased volatility in the markets. That’s why investors should consider diversifying their portfolios with international technology stocks.

Now Cash Flow Positive on Cruises, Carnival Is Set to Go Higher

By Mark R. Hake, CFA
Carnival is now cash flow positive on its cruises. That could lead to a higher CCL stock price of around $32 based on forecast earnings.

Dutch Bros Could Rise 18% More Despite Post-IPO Price Gains

By Mark R. Hake, CFA
Dutch Bros may not be as overvalued as it seems. BROS stock could be worth $51 based on its past and future growth rates.

ROKU Stock Continues to Create Profits for Loyal Fans

By Nicolas Chahine, InvestorPlace Contributor
ROKU stock financial metrics are healthy. As long as the equity markets are healthy then this one is a keeper for the long term.

Clover Health Has Multiple Catalysts Converging to Move It Forward

By David Moadel, InvestorPlace Contributor
CLOV stock owners should be proud to invest in a business that helps seniors get health care while also providing solid shareholder value.

DraftKings Is a Wild Card Now, But It Remains a Solid Long-Term Bet

By Nicolas Chahine, InvestorPlace Contributor
DKNG stock acts erratic, but that's because Wall Street is on edge. In the long run, DraftKings has the odds stacked on its side.

7 Meme Stocks to Buy for a Q4 Rally

By Bret Kenwell, InvestorPlace Contributor
Meme stocks have become a rage on Wall Street throughout 2021. But is there more to come in Q4 for meme stocks to buy on Wall Street?
Load More Articles